A Study To Assess Esreboxetine's Effect On Concentration, Memory, Decision Making And Problem Solving In Patients With Fibromyalgia.
Clinical trial NCT00752505 · COMPLETED
Trial details
- NCT number
- NCT00752505
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2009-06-01
- Enrollment
- 89
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.